HCSG (HCSG) director converts 2026 board fees into Deferred Stock Units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

HEALTHCARE SERVICES GROUP INC director Laura K. Grant received a compensatory stock award rather than making an open-market trade. On this Form 4, she acquired 306 shares of common stock on June 30, 2026 at a reference price of $24.56 per share as a grant or award.

Grant has elected to receive fully vested Deferred Stock Units (DSUs) under the company’s 2020 Amended Omnibus Incentive Plan instead of cash fees for serving on the Board and its committees. The number of DSUs is based on her fees divided by the issuer’s closing stock price on the payment date, rounded up to the nearest whole share.

After this grant, she directly holds 18,314 shares, consisting of 1,969 unvested DSUs and 16,345 vested DSUs. The DSUs will be settled in shares of common stock 90 days after she leaves the Board, and she may elect an additional deferral in line with Code Section 409A rules.

Insider Trade Summary 10b5-1

1 transaction reported

Mixed 1 txn

Insider Grant Laura K

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	306	$24.56	$8K

Holdings After Transaction: Common Stock — 18,314 shares (Direct, null)

Footnotes (1)

The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to the director's fees earned in 2026 in compliance with the issuer's black-out period guidelines. The number of shares represents the quotient of the amount of such fees divided by the issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock ninety days following separation of service from the Board. The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A. Amount represents 1,969 unvested DSUs and 16,345 vested DSUs.

Key Figures

Shares granted: 306 shares Grant reference price: $24.56 per share Total shares after transaction: 18,314 shares +1 more

4 metrics

Shares granted 306 shares Common stock grant on June 30, 2026

Grant reference price $24.56 per share Used to convert 2026 director fees into DSUs

Total shares after transaction 18,314 shares Direct holdings following the June 30, 2026 grant

Vested vs. unvested DSUs 16,345 vested; 1,969 unvested Breakdown of Grant’s Deferred Stock Units

Key Terms

Deferred Stock Units, 2020 Amended Omnibus Incentive Plan, black-out period guidelines, Code Section 409A, +1 more

5 terms

Deferred Stock Units financial

"fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

2020 Amended Omnibus Incentive Plan financial

"under the Issuer's 2020 Amended Omnibus Incentive Plan in lieu of cash fees"

black-out period guidelines regulatory

"election in 2025 which applies to the director's fees earned in 2026 in compliance with the issuer's black-out period guidelines"

Code Section 409A regulatory

"The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A."

Deferred Stock Units ("DSUs") financial

"The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:08 PM Accepted by SEC EDGAR 07/02/2026 - 04:06 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grant Laura K

(Last)

(First)

(Middle)

3220 TILLMAN DRIVE

SUITE 300

(Street)

BENSALEM

PENNSYLVANIA

19020

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/30/2026		A		306	A	$24.56⁽¹⁾	18,314⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to the director's fees earned in 2026 in compliance with the issuer's black-out period guidelines. The number of shares represents the quotient of the amount of such fees divided by the issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock ninety days following separation of service from the Board. The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.

2. Amount represents 1,969 unvested DSUs and 16,345 vested DSUs.

Remarks:

	Michael Harrity, by Power of Attorney	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did HCSG director Laura K. Grant report?

Laura K. Grant reported receiving 306 shares of HCSG common stock as a grant, not an open-market purchase. The award reflects director fees converted into Deferred Stock Units under the company’s 2020 Amended Omnibus Incentive Plan at a reference price of $24.56 per share.

How many HEALTHCARE SERVICES GROUP (HCSG) shares does Laura K. Grant hold after this Form 4?

After the reported grant, Laura K. Grant directly holds 18,314 HCSG shares. These consist of 1,969 unvested Deferred Stock Units and 16,345 vested Deferred Stock Units, all tied to her service on the Board of Directors and related committees.

How are HCSG director fees converted into shares for Laura K. Grant?

Laura K. Grant elected to receive director fees as fully vested Deferred Stock Units instead of cash. The company calculates DSUs by dividing the fee amount by the closing stock price on the fee payment date, then rounding up to the nearest whole share, per the 2020 incentive plan.

When will Laura K. Grant’s Deferred Stock Units in HCSG be settled?

Her Deferred Stock Units will be settled in HCSG common stock 90 days after she separates from the Board. She may also elect to defer settlement further, consistent with the rules of Internal Revenue Code Section 409A and the company’s plan provisions.

What is the price reference used for Laura K. Grant’s HCSG stock grant?

The reported 306-share grant uses a reference price of $24.56 per share. This corresponds to the issuer’s closing stock price on the date the director fees would otherwise be paid, which is used to convert cash fees into Deferred Stock Units under the incentive plan.

Is Laura K. Grant’s HCSG Form 4 transaction a market buy or compensation award?

The transaction is a compensation-related award, coded as a grant or other acquisition. Laura K. Grant elected to receive Deferred Stock Units in lieu of cash director fees, so no open-market purchase or sale of HEALTHCARE SERVICES GROUP INC shares is reported here.